RFXCEL CORP

Lobbying Spend

—

Filings

Firms Hired

Active Period

2006–2007

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2007	—	3	1
2006	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BROWNSTEIN HYATT FARBER SCHRECK, LLP	—	6

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	5
SENATE	5
Food & Drug Administration (FDA)	4
Centers For Disease Control & Prevention (CDC)	3
Health & Human Services, Dept of (HHS)	1

Most frequently reported lobbying issues

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3161108th Congress

To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.

Cited source text and reported amounts

Prescription Drug Pedigree Requirement H.R.3161-House Agriculture Appropriations Bill S.1082-Prescription Drug Users Fee Act

Client expense: — · Firm income: $40,000

Matched citations: H.R.3161

H.R. 3161108th Congress

To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.

Cited source text and reported amounts

Prescription Drug Pedigree Requirement H.R.3161-House Agriculture Appropriations Bill S.1082-Prescription Drug Users Fee Act

Client expense: — · Firm income: $40,000

Matched citations: H.R.3161

H.R. 3161108th Congress

To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.

Cited source text and reported amounts

Prescription Drug Pedigree Requirement H.R.3161-House Agriculture Appropriations Bill S.1082-Prescription Drug Users Fee Act

Client expense: — · Firm income: $40,000

Matched citations: H.R.3161

RFXCEL CORP — Lobbying Disclosure | Poliscope